Publications from Johnson & Johnson, page 3
A filtered view. Show the full list.
Refine
Listings
-
ArticleAdvances in therapy
Teclistamab Plus Daratumumab Versus Standard Daratumumab-Based Proteasome Inhibitor Combinations for Relapsed/Refractory Multiple Myeloma: An Inverse Probability of Treatment Weighting Analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleDermatology and therapy
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, University of Pennsylvania. Affiliation source
Disease researchAdded
-
ArticleDermatology and therapy
Efficacy and Safety of the PD-1 Agonist JNJ-67484703 in Participants with Atopic Dermatitis: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Results
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleDermatology and therapy
Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewCNS drugs
The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewDrug safety
Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ReviewPharmacoEconomics
A Systematic Literature Review on the Economic Burden of Sjögren's Disease
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, University of Pennsylvania, with Drexel University linked by the institution reference. Affiliation source
Public healthAdded
-
ArticlePharmaceutical medicine
Best Practices for Medical Information Global Response Documents from phactMI and MILE
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleOncology and therapy
Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleOncology and therapy
Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleOncology and therapy
IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel Treatment
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleOncology and therapy
A Qualitative Study of Patient and Caregiver Perspectives on Locally Advanced Head and Neck Cancer in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewRheumatology and therapy
Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewRheumatology and therapy
Humanistic Burden of Sjögren's Disease: A Systematic Review of Treatment Efficacy on Health-Related Quality of Life
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, University of Pennsylvania, with Drexel University linked by the institution reference. Affiliation source
Clinical careAdded
-
ArticleDrugs - real world outcomes
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleDrugs - real world outcomes
Complications and Occurrence of Exacerbations in Patients with Myasthenia Gravis Treated with Oral Corticosteroids
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewPulmonary therapy
Practical Considerations for Managing Transitions from Parenteral Prostacyclins to Oral Selexipag in Pulmonary Arterial Hypertension
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticlePharmacoEconomics - open
Valuing Maintenance of Visual Function in Retinitis Pigmentosa: A Discrete Choice Experiment with Patients and the General Public
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ReviewAdvanced drug delivery reviews
High-Dose Subcutaneous Administration of Biologics: Overcoming Barriers Through Formulation and Device Innovation
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
Clinical trial reportAnnals of the rheumatic diseases
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleAnnals of the rheumatic diseases
Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source
Clinical careAdded
-
ArticleAnnals of the rheumatic diseases
PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleBiologicals : journal of the International Association of Biological Standardization
Leveraging analytical and bioprocess platforms for biological product development and commercialization - A meeting report
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleBiological psychiatry global open science
Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded